Cerus Corporation (CERS) Stock

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

280 people get CERS articles and Market Currents by email alert.

Get email alerts on CERS »

CERS Market Currents more »

February 29 Premarket gainers: CERS +10%. NKTR +10%. VVUS +6%. CHTP +5%. MDW +5%. IRE +3%. NBG +3%.
Losers: CEDC -28%. SODA -12%. GNTX -10%. CPST -8%. FSLR -7%. KOG -6%. TAL -5%. EXLP -5%. PANL -5%. KYN -5%. MHR -4%.
1 Comment
[On the Move]

CERS in Focus more »

CERS Related Articles more »

CERS News more »

Stocks to Watch: RIMM, AAPL & More

at CNBC.com (Apr 16, 2012)
Cerus's French connection

at MarketWatch.com (Mar 8, 2012)
Biotech Stocks: Biotech analysts lukewarm on diagnostic stocks

at MarketWatch.com (Sep 29, 2011)
Movers & Shakers: Friday’s biggest gaining and declining stocks

at MarketWatch.com (Mar 4, 2011)
Outside the Box: The best biotech stocks to own now

at MarketWatch.com (Jan 13, 2011)

CERS Press Releases and Filings more »

Cerus Corporation Reports First Quarter 2012 Results

Business Wire (May 1, 2012)
Cerus, the University Hospitals of Geneva, and the Transfusion Service of the Swiss Red Cross Intend to Collaborate on Whole Blood Pathogen Inactivation for Africa

Business Wire (Apr 30, 2012)
Cerus and New York Blood Center to Collaborate on Development of Novel Red Blood Cell Biologic Product with Improved Uniformity

Business Wire (Apr 24, 2012)
Cerus Announces First INTERCEPT Platelet System Customer in Austria

Business Wire (Apr 18, 2012)
Cerus to Release First Quarter 2012 Results on May 1, 2012

Business Wire (Apr 12, 2012)

CERS Latest Transcript more »

Currently, there are no transcripts for CERS.

CERS Cramer more »

Currently, there are no Cramer articles on CERS.

CERS Instablog posts more »

Write a post on CERS

CERS StockTalks

CERS vs. ETF Alternatives

Company Description

Currently, there's no company description for CERS.

Sector: Healthcare

Industry: Biotechnology

Country: United States